HEADER TRANSFERASE 08-DEC-17 6F7B TITLE CRYSTAL STRUCTURE OF THE HUMAN BUB1 KINASE DOMAIN IN COMPLEX WITH BAY TITLE 2 1816032 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MITOTIC CHECKPOINT SERINE/THREONINE-PROTEIN KINASE BUB1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: HBUB1,BUB1A; COMPND 5 EC: 2.7.11.1; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: BUB1, BUB1L; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS BUB1, KINASE INHIBITOR, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.J.HOLTON,G.SIEMEISTER,A.MENGEL,W.BONE,J.SCHROEDER,S.ZITZMANN-KOLBE, AUTHOR 2 H.BRIEM,A.FERNANDEZ-MONTALVAN,S.PRECHTL,U.MOENNING,O.VON AHSEN, AUTHOR 3 J.JOHANSSEN,A.CLEVE,V.PUETTER,M.HITCHCOCK,F.VON NUSSBAUM,M.BRANDS, AUTHOR 4 D.MUMBERG,K.ZIEGELBAUER REVDAT 3 05-MAY-21 6F7B 1 REMARK REVDAT 2 24-APR-19 6F7B 1 JRNL REVDAT 1 19-DEC-18 6F7B 0 JRNL AUTH G.SIEMEISTER,A.MENGEL,A.E.FERNANDEZ-MONTALVAN,W.BONE, JRNL AUTH 2 J.SCHRODER,S.ZITZMANN-KOLBE,H.BRIEM,S.PRECHTL,S.J.HOLTON, JRNL AUTH 3 U.MONNING,O.VON AHSEN,S.JOHANSSEN,A.CLEVE,V.PUTTER, JRNL AUTH 4 M.HITCHCOCK,F.VON NUSSBAUM,M.BRANDS,K.ZIEGELBAUER,D.MUMBERG JRNL TITL INHIBITION OF BUB1 KINASE BY BAY 1816032 SENSITIZES TUMOR JRNL TITL 2 CELLS TOWARD TAXANES, ATR, AND PARP INHIBITORSIN VITROANDIN JRNL TITL 3 VIVO. JRNL REF CLIN.CANCER RES. V. 25 1404 2019 JRNL REFN ISSN 1078-0432 JRNL PMID 30429199 JRNL DOI 10.1158/1078-0432.CCR-18-0628 REMARK 2 REMARK 2 RESOLUTION. 2.00 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0158 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.00 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 25037 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.201 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.254 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1298 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.00 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.05 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1805 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.89 REMARK 3 BIN R VALUE (WORKING SET) : 0.2560 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.2900 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2789 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 40 REMARK 3 SOLVENT ATOMS : 169 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 40.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.02000 REMARK 3 B22 (A**2) : 0.02000 REMARK 3 B33 (A**2) : -0.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.197 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.180 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.121 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 4.338 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.928 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2968 ; 0.011 ; 0.019 REMARK 3 BOND LENGTHS OTHERS (A): 2746 ; 0.002 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4020 ; 1.497 ; 1.981 REMARK 3 BOND ANGLES OTHERS (DEGREES): 6375 ; 0.937 ; 3.001 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 354 ; 6.003 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 134 ;36.587 ;24.627 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 529 ;13.925 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 10 ;10.976 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 424 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 3253 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 595 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1404 ; 2.702 ; 3.949 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1403 ; 2.702 ; 3.947 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1762 ; 4.125 ; 5.894 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1763 ; 4.125 ; 5.897 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1564 ; 2.713 ; 4.270 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1564 ; 2.711 ; 4.270 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 2258 ; 4.466 ; 6.263 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 3335 ; 6.598 ;44.078 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 3310 ; 6.586 ;43.958 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 6F7B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 08-DEC-17. REMARK 100 THE DEPOSITION ID IS D_1200007867. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.26 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 26378 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.000 REMARK 200 RESOLUTION RANGE LOW (A) : 46.790 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 6.500 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 21.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.00 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.05 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 45.96 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 200MM MGCL2, 100MM TRIS-HCL PH 7.26, REMARK 280 5% GLYCEROL, 20% PEG 3350, VAPOR DIFFUSION, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,-Y,-Z+1/2 REMARK 290 4555 -X+1/2,-Y,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 25.24850 REMARK 290 SMTRY2 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 62.23450 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 25.24850 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 62.23450 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 16750 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A1253 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 725 REMARK 465 SER A 726 REMARK 465 SER A 727 REMARK 465 LEU A 728 REMARK 465 GLY A 729 REMARK 465 THR A 730 REMARK 465 VAL A 731 REMARK 465 ASP A 732 REMARK 465 GLY A 807 REMARK 465 ASP A 808 REMARK 465 LEU A 809 REMARK 465 ASN A 810 REMARK 465 ASP A 811 REMARK 465 ALA A 812 REMARK 465 GLY A 1010 REMARK 465 GLY A 1011 REMARK 465 ARG A 1084 REMARK 465 LYS A 1085 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 806 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 921 O HOH A 1201 1.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 768 58.80 -94.90 REMARK 500 ALA A 797 -119.07 48.59 REMARK 500 LYS A 887 -39.46 75.30 REMARK 500 ASP A 917 50.59 -151.27 REMARK 500 ASP A 946 95.46 69.54 REMARK 500 ASN A 983 -92.01 -135.95 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A1102 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 917 OD2 REMARK 620 2 GLN A 949 OE1 90.1 REMARK 620 3 SEP A 969 O2P 91.6 88.6 REMARK 620 4 HOH A1219 O 83.2 172.5 88.1 REMARK 620 5 HOH A1240 O 175.4 93.9 90.7 92.9 REMARK 620 6 HOH A1284 O 89.4 86.4 174.9 97.0 88.6 REMARK 620 N 1 2 3 4 5 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue CVQ A 1101 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue MG A 1102 DBREF 6F7B A 726 1085 UNP O43683 BUB1_HUMAN 726 1085 SEQADV 6F7B GLY A 725 UNP O43683 EXPRESSION TAG SEQRES 1 A 361 GLY SER SER LEU GLY THR VAL ASP ALA PRO ASN PHE ILE SEQRES 2 A 361 VAL GLY ASN PRO TRP ASP ASP LYS LEU ILE PHE LYS LEU SEQRES 3 A 361 LEU SER GLY LEU SER LYS PRO VAL SER SER TYR PRO ASN SEQRES 4 A 361 THR PHE GLU TRP GLN CYS LYS LEU PRO ALA ILE LYS PRO SEQRES 5 A 361 LYS THR GLU PHE GLN LEU GLY SER LYS LEU VAL TYR VAL SEQRES 6 A 361 HIS HIS LEU LEU GLY GLU GLY ALA PHE ALA GLN VAL TYR SEQRES 7 A 361 GLU ALA THR GLN GLY ASP LEU ASN ASP ALA LYS ASN LYS SEQRES 8 A 361 GLN LYS PHE VAL LEU LYS VAL GLN LYS PRO ALA ASN PRO SEQRES 9 A 361 TRP GLU PHE TYR ILE GLY THR GLN LEU MET GLU ARG LEU SEQRES 10 A 361 LYS PRO SER MET GLN HIS MET PHE MET LYS PHE TYR SER SEQRES 11 A 361 ALA HIS LEU PHE GLN ASN GLY SER VAL LEU VAL GLY GLU SEQRES 12 A 361 LEU TYR SER TYR GLY THR LEU LEU ASN ALA ILE ASN LEU SEQRES 13 A 361 TYR LYS ASN THR PRO GLU LYS VAL MET PRO GLN GLY LEU SEQRES 14 A 361 VAL ILE SER PHE ALA MET ARG MET LEU TYR MET ILE GLU SEQRES 15 A 361 GLN VAL HIS ASP CYS GLU ILE ILE HIS GLY ASP ILE LYS SEQRES 16 A 361 PRO ASP ASN PHE ILE LEU GLY ASN GLY PHE LEU GLU GLN SEQRES 17 A 361 ASP ASP GLU ASP ASP LEU SER ALA GLY LEU ALA LEU ILE SEQRES 18 A 361 ASP LEU GLY GLN SER ILE ASP MET LYS LEU PHE PRO LYS SEQRES 19 A 361 GLY THR ILE PHE THR ALA LYS CYS GLU THR SEP GLY PHE SEQRES 20 A 361 GLN CYS VAL GLU MET LEU SER ASN LYS PRO TRP ASN TYR SEQRES 21 A 361 GLN ILE ASP TYR PHE GLY VAL ALA ALA THR VAL TYR CYS SEQRES 22 A 361 MET LEU PHE GLY THR TYR MET LYS VAL LYS ASN GLU GLY SEQRES 23 A 361 GLY GLU CYS LYS PRO GLU GLY LEU PHE ARG ARG LEU PRO SEQRES 24 A 361 HIS LEU ASP MET TRP ASN GLU PHE PHE HIS VAL MET LEU SEQRES 25 A 361 ASN ILE PRO ASP CYS HIS HIS LEU PRO SER LEU ASP LEU SEQRES 26 A 361 LEU ARG GLN LYS LEU LYS LYS VAL PHE GLN GLN HIS TYR SEQRES 27 A 361 THR ASN LYS ILE ARG ALA LEU ARG ASN ARG LEU ILE VAL SEQRES 28 A 361 LEU LEU LEU GLU CYS LYS ARG SER ARG LYS MODRES 6F7B SEP A 969 SER MODIFIED RESIDUE HET SEP A 969 10 HET CVQ A1101 39 HET MG A1102 1 HETNAM SEP PHOSPHOSERINE HETNAM CVQ 2-[3,5-BIS(FLUORANYL)-4-[[3-[5-METHOXY-4-[(3- HETNAM 2 CVQ METHOXYPYRIDIN-4-YL)AMINO]PYRIMIDIN-2-YL]INDAZOL-1- HETNAM 3 CVQ YL]METHYL]PHENOXY]ETHANOL HETNAM MG MAGNESIUM ION HETSYN SEP PHOSPHONOSERINE FORMUL 1 SEP C3 H8 N O6 P FORMUL 2 CVQ C27 H24 F2 N6 O4 FORMUL 3 MG MG 2+ FORMUL 4 HOH *169(H2 O) HELIX 1 AA1 ASP A 743 GLY A 753 1 11 HELIX 2 AA2 PRO A 757 TYR A 761 5 5 HELIX 3 AA3 ASN A 827 LEU A 841 1 15 HELIX 4 AA4 LYS A 842 PHE A 849 5 8 HELIX 5 AA5 THR A 873 LYS A 882 1 10 HELIX 6 AA6 PRO A 890 CYS A 911 1 22 HELIX 7 AA7 LYS A 919 ASP A 921 5 3 HELIX 8 AA8 GLY A 926 GLN A 932 1 7 HELIX 9 AA9 LYS A 954 PHE A 956 5 3 HELIX 10 AB1 CYS A 973 SER A 978 1 6 HELIX 11 AB2 TYR A 984 GLY A 1001 1 18 HELIX 12 AB3 HIS A 1024 ASN A 1037 1 14 HELIX 13 AB4 SER A 1046 TYR A 1062 1 17 HELIX 14 AB5 LYS A 1065 ARG A 1082 1 18 SHEET 1 AA1 2 PHE A 736 VAL A 738 0 SHEET 2 AA1 2 THR A 960 PHE A 962 1 O ILE A 961 N VAL A 738 SHEET 1 AA2 7 THR A 764 GLU A 766 0 SHEET 2 AA2 7 PHE A 852 LEU A 857 1 O LEU A 857 N PHE A 765 SHEET 3 AA2 7 SER A 862 GLY A 866 -1 O VAL A 865 N TYR A 853 SHEET 4 AA2 7 LYS A 817 GLN A 823 -1 N VAL A 819 O GLY A 866 SHEET 5 AA2 7 ALA A 799 THR A 805 -1 N ALA A 804 O PHE A 818 SHEET 6 AA2 7 LYS A 785 GLY A 796 -1 N GLY A 794 O VAL A 801 SHEET 7 AA2 7 GLU A 779 LEU A 782 -1 N PHE A 780 O VAL A 787 SHEET 1 AA3 2 ILE A 913 ILE A 914 0 SHEET 2 AA3 2 ILE A 951 ASP A 952 -1 O ILE A 951 N ILE A 914 SHEET 1 AA4 2 PHE A 923 LEU A 925 0 SHEET 2 AA4 2 LEU A 942 LEU A 944 -1 O ALA A 943 N ILE A 924 SHEET 1 AA5 2 VAL A1006 LYS A1007 0 SHEET 2 AA5 2 LYS A1014 PRO A1015 -1 O LYS A1014 N LYS A1007 LINK C THR A 968 N SEP A 969 1555 1555 1.34 LINK C SEP A 969 N GLY A 970 1555 1555 1.34 LINK OD2 ASP A 917 MG MG A1102 1555 1555 2.00 LINK OE1 GLN A 949 MG MG A1102 1555 1555 2.08 LINK O2P SEP A 969 MG MG A1102 1555 1555 2.16 LINK MG MG A1102 O HOH A1219 1555 1555 2.09 LINK MG MG A1102 O HOH A1240 1555 1555 2.21 LINK MG MG A1102 O HOH A1284 1555 1555 2.18 CISPEP 1 LYS A 824 PRO A 825 0 2.06 SITE 1 AC1 14 VAL A 819 LYS A 821 GLU A 830 GLY A 834 SITE 2 AC1 14 PHE A 849 MET A 850 PHE A 852 LEU A 864 SITE 3 AC1 14 GLU A 867 TYR A 869 ILE A 924 ILE A 945 SITE 4 AC1 14 ASP A 946 LEU A 947 SITE 1 AC2 6 ASP A 917 GLN A 949 SEP A 969 HOH A1219 SITE 2 AC2 6 HOH A1240 HOH A1284 CRYST1 50.497 60.093 124.469 90.00 90.00 90.00 P 21 2 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019803 0.000000 0.000000 0.00000 SCALE2 0.000000 0.016641 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008034 0.00000